Vitamin D in Corona Virus Disease 2019 (COVID-19) Related Multisystem Inflammatory Syndrome in Children (MIS-C)

Area of Science:

• Immunology
• Pediatrics
• Infectious Diseases

Background:

• Multisystem Inflammatory Syndrome in children (MIS-C) is a severe complication of COVID-19.
• Prognostic biomarkers and novel treatments are crucial for improving MIS-C outcomes.
• Vitamin D's immunomodulatory effects suggest a potential role in viral infections and MIS-C.

Purpose of the Study:

• To review the immunomodulatory role of vitamin D in viral infections, particularly COVID-19.
• To examine the association between vitamin D levels and MIS-C and Kawasaki disease.
• To evaluate vitamin D as both a prognostic biomarker and a nutritional supplement for MIS-C.

Main Methods:

• Literature review analyzing the immunomodulatory functions of vitamin D.
• Examination of existing studies on vitamin D and MIS-C.
• Assessment of vitamin D's role in Kawasaki disease for comparative insights.

Main Results:

• Vitamin D levels may serve as a valuable biomarker for predicting severe forms of MIS-C.
• Correction of vitamin D deficiency in severe MIS-C could potentially influence disease progression.
• Vitamin D supplementation may reduce MIS-C severity in specific contexts.

Conclusions:

• Vitamin D status is potentially significant in managing MIS-C.
• Further clinical studies are required to validate the therapeutic benefits of vitamin D supplementation in MIS-C.
• Vitamin D holds promise as an adjunct therapy for severe MIS-C.